Skip to main content
. Author manuscript; available in PMC: 2013 Sep 30.
Published in final edited form as: J Pharmacol Sci. 2013 May 22;122(2):103–108. doi: 10.1254/jphs.13045fp

Fig. 3.

Fig. 3

Plasma (A) and kidney (B) Ang II levels. A: Plasma Ang II did not significantly respond to Ang I infusion with or without temocapril treatment. Olmesartan increased plasma Ang II levels. B: Kidney Ang II levels increased at weeks 2 and 4 following Ang I infusion. Temocapril suppresses the increase in renal Ang II at week 2, but not at week 4. Olmesartan suppressed renal Ang II levels both at weeks 2 and 4. *P < 0.05 vs. vehicle-infused group, #P < 0.05 vs. Ang I + control group.